CLINICAL_TRIALS
trial_result
· 2012-06-04
Clinical Trial Update: Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients [Phase 1]
Summary
Phase 1 trial assessing SB681323 with prednisolone on biomarkers in chronic obstructive pulmonary disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED